144 related articles for article (PubMed ID: 35181964)
1. Prognostic impact of count of extratumoral lymphatic permeation in lung adenocarcinoma and its relation to the immune microenvironment.
Niimi T; Nakai T; Aokage K; Tane K; Miyoshi T; Samejima J; Miyazaki S; Taki T; Sakamoto N; Sakashita S; Watanabe R; Kojima M; Suzuki K; Tsuboi M; Ishii G
Cancer Sci; 2022 Apr; 113(4):1497-1506. PubMed ID: 35181964
[TBL] [Abstract][Full Text] [Related]
2. Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma.
Kinoshita F; Takada K; Yamada Y; Oku Y; Kosai K; Ono Y; Tanaka K; Wakasu S; Oba T; Osoegawa A; Tagawa T; Shimokawa M; Oda Y; Mori M
Ann Surg Oncol; 2020 Jun; 27(6):2102-2109. PubMed ID: 31773516
[TBL] [Abstract][Full Text] [Related]
3. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
[TBL] [Abstract][Full Text] [Related]
4. The landscape of immune microenvironment in lung adenocarcinoma and squamous cell carcinoma based on PD-L1 expression and tumor-infiltrating lymphocytes.
Chen L; Cao MF; Zhang X; Dang WQ; Xiao JF; Liu Q; Tan YH; Tan YY; Xu YY; Xu SL; Yao XH; Cui YH; Zhang X; Bian XW
Cancer Med; 2019 Dec; 8(17):7207-7218. PubMed ID: 31605439
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of extratumoral lymphatic permeation in non-small cell lung cancer as a means of predicting outcome.
Saijo T; Ishii G; Ochiai A; Hasebe T; Yoshida J; Nishimura M; Nagai K
Lung Cancer; 2007 Jan; 55(1):61-6. PubMed ID: 17134789
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the tumor immune-microenvironment of lung adenocarcinoma associated with usual interstitial pneumonia.
Ueda T; Aokage K; Mimaki S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Kusumoto M; Suzuki K; Tsuchihara K; Nishikawa H; Goto K; Tsuboi M; Ishii G
Lung Cancer; 2018 Dec; 126():162-169. PubMed ID: 30527182
[TBL] [Abstract][Full Text] [Related]
7. Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.
Kadota K; Yeh YC; Villena-Vargas J; Cherkassky L; Drill EN; Sima CS; Jones DR; Travis WD; Adusumilli PS
Chest; 2015 Sep; 148(3):711-721. PubMed ID: 25836013
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence.
Suzuki K; Kadota K; Sima CS; Nitadori J; Rusch VW; Travis WD; Sadelain M; Adusumilli PS
J Clin Oncol; 2013 Feb; 31(4):490-8. PubMed ID: 23269987
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of tumor-infiltrating lymphocytes in non-small cell lung carcinomas.
Mlika M; Saidi A; Mejri N; Abdennadher M; Haddouchi C; Labidi S; Khiari H; Boussen H; Hsairi M; Mezni F
Asian Cardiovasc Thorac Ann; 2022 Feb; 30(2):177-184. PubMed ID: 34558296
[TBL] [Abstract][Full Text] [Related]
10. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer.
Kinoshita T; Muramatsu R; Fujita T; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Kudo-Saito C; Hayashi Y; Kamiyama I; Ohtsuka T; Asamura H; Kawakami Y
Ann Oncol; 2016 Nov; 27(11):2117-2123. PubMed ID: 27502728
[TBL] [Abstract][Full Text] [Related]
12. Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival.
Pocha K; Mock A; Rapp C; Dettling S; Warta R; Geisenberger C; Jungk C; Martins LR; Grabe N; Reuss D; Debus J; von Deimling A; Abdollahi A; Unterberg A; Herold-Mende CC
Clin Cancer Res; 2020 May; 26(9):2231-2243. PubMed ID: 31953311
[TBL] [Abstract][Full Text] [Related]
13. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.
Shin SJ; Kim SY; Choi YY; Son T; Cheong JH; Hyung WJ; Noh SH; Park CG; Kim HI
Oncologist; 2019 Sep; 24(9):e835-e844. PubMed ID: 30894409
[TBL] [Abstract][Full Text] [Related]
14. 18F-fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma.
Nomura K; Nakai T; Nishina Y; Sakamoto N; Miyoshi T; Tane K; Samejima J; Aokage K; Kojima M; Sakashita S; Taki T; Miyazaki S; Watanabe R; Suzuki K; Tsuboi M; Ishii G
Cancer Sci; 2022 Apr; 113(4):1488-1496. PubMed ID: 35023268
[TBL] [Abstract][Full Text] [Related]
15. Impact of extratumoral lymphatic permeation on postoperative survival of non-small-cell lung cancer patients.
Matsumura Y; Hishida T; Shimada Y; Ishii G; Aokage K; Yoshida J; Nagai K
J Thorac Oncol; 2014 Mar; 9(3):337-44. PubMed ID: 24496002
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of alveolar collapse in lung invasive adenocarcinoma and its relationship with tumor infiltrating lymphocytes.
Shen Y; Li L; Yang Z; Wen Y; Qian L; He H
Pathol Res Pract; 2024 Feb; 254():155149. PubMed ID: 38277751
[TBL] [Abstract][Full Text] [Related]
17. Effect of combined epidural anaesthesia on tumor-infiltrating lymphocytes in lung adenocarcinoma: a prospective exploratory sub-analysis.
Li MH; Xu ZZ; Huang SM; Li T; Li XY; Wang DX
Acta Anaesthesiol Scand; 2018 May; 62(5):687-700. PubMed ID: 29363103
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer.
Handa Y; Tsutani Y; Shiroma N; Kai Y; Mimae T; Miyata Y; Takeshima Y; Arihiro K; Okada M
Clin Lung Cancer; 2020 Jul; 21(4):e302-e314. PubMed ID: 32102750
[TBL] [Abstract][Full Text] [Related]
19. NRAS expression is associated with prognosis and tumor immune microenvironment in lung adenocarcinoma.
Yan Y; Gao Z; Han H; Zhao Y; Zhang Y; Ma X; Chen H
J Cancer Res Clin Oncol; 2022 Mar; 148(3):565-575. PubMed ID: 34746975
[TBL] [Abstract][Full Text] [Related]
20. FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-III.
Jiang M; Wu C; Zhang L; Sun C; Wang H; Xu Y; Sun H; Zhu J; Zhao W; Fang Q; Yu J; Chen P; Wu S; Zheng Z; He Y; Zhou C
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34006632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
